Cyclobenzaprine Hydrochloride Capsule, Extended Release
Product Images NDC 71335-2514

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Cyclobenzaprine Hydrochloride (NDC 71335-2514). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Image 1)

Structural Formula (Image 1)
Chemical structure of Cyclobenzaprine Hydrochloride, showing the molecular framework with aromatic rings and associated functional groups as depicted.*
FDA Label Image

Image (Image 2)

Image (Image 2)
An illustration showing a close-up of a spoon holding a serving of mashed or pureed food. The image is likely instructional or related to feeding.*
FDA Label Image

Image (Image 3)

Image (Image 3)
An instructional illustration showing hands handling a capsule labeled 'TOP'. The diagram likely demonstrates how to hold or orient the capsule correctly, relevant for Cyclobenzaprine Hydrochloride extended-release capsules.*
FDA Label Image

Image (Image 4)

FDA Label Image

Image (Image 5)

Image (Image 5)
Illustration showing a hand opening a capsule and pouring its contents, consisting of small pellets or granules, onto a spoon. This image demonstrates an administration method for capsule contents.*
FDA Label Image

Image (Image 6)

Image (Image 6)
An illustration showing a woman holding a spoon with medication, depicted in profile view, suggesting the oral administration of a drug.*
FDA Label Image

Image (Image 7)

Image (Image 7)
An instructional illustration showing a person drinking a glass of water, suggesting the method for oral administration of a medication.*
FDA Label Image

Label (Lbl713352514)

Label (Lbl713352514)
Cyclobenzaprine Hydrochloride 15 mg extended-release capsules label showing product NDC 71335-2514-1. The label indicates 30 capsules in the package and includes storage instructions, a dosage note, and QR codes for additional information. It is repackaged by Bryant Ranch Prepack and manufactured by TWi Pharmaceuticals, Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.